RARE ELEMENT RESOURCES LTD
For the period ended Dec 31, 2025. Filed Mar 12, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 12, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 11. EXECUTIVE COMPENSATION
The following discussion summarizes our compensation program for our named executive officers for the 2025 fiscal year (amounts stated in whole dollars).
Named Executive Officers
“Named Executive Officer” or “NEO” means (a) all individuals who served as CEO of the Company during the fiscal year ended December 31, 2025; (b) each of the two most highly compensated executive officers, or the two most highly compensated individuals acting in a similar capacity, other than the CEO, at the end of the fiscal year ended December 31, 2025; and (c) each individual who would be an NEO under clause (b) above but for the fact that the individual was neither an executive officer of the Company, nor acting in a similar capacity, at the end of that fiscal year.
During the fiscal year ended December 31, 2025, the Company had three NEOs: Kenneth J. Mushinski, President and CEO; Kelli C. Kast, Vice President, General Counsel and Chief Administrative Officer; and Wayne E. Rich, Chief Financial Officer.
Summary Compensation Table
Set out below is a summary of compensation paid to the Company’s NEOs during the fiscal years ended December 31, 2025 and 2024.
| · · · · · · · · · · | ||||||
|---|---|---|---|---|---|---|
| Name and Principal Position · · Year · · Salary ($) · · Bonus ($) · · All Other Compensation ($) · · Total ($) | ||||||
| Kenneth J. Mushinski (1) | | 2025 | $350,000 | $175,000 | $30,000 | $555,000 |
| President, CEO and Director | | 2024 | $213,333 | $185,000 | $11,690 | $410,023 |
| Kelli C Kast (2) | | 2025 | $316,200 | $85,000 | $28,200 | $429,400 |
| VP, General Counsel, CAO | | 2024 | $282,500 | $100,000 | $35,500 | $418,000 |
| Wayne E. Rich (3) | | 2025 | $275,000 | $75,000 | $28,200 | $378,200 |
| Chief Financial Officer | | 2024 | $250,000 | $70,000 | $18,575 | $338,575 |
(1) Mr. Mushinski was appointed as the President and Chief Executive Officer of the Company on May 1, 2024. During 2024, Mr. Mushinski was paid a $60,000 signing bonus and earned a $125,000 discretionary bonus which was paid in January 2025. During 2025, Mr. Mushinski earned a $175,000 discretionary bonus which was paid in January 2026. During 2024, all other compensation includes a $2,000 cell phone allowance and a $9,690 employer 401K matching contribution. During 2025, all other compensation includes $6,000 healthcare allowance, $3,000 cell phone allowance and $21,000 employer 401K matching contribution.
| (2) | From June 2015 to June 30, 2024, Ms. Kast served as a consultant to Rare Element Resources, Inc., a subsidiary of the Company and from August 23, 2022 to August 20, 2024, Ms. Kast served as a director of the Company. As a director and consultant, Ms. Kast received pay of $27,750 and $127,500, respectively, before her hire as a Company employee. From March 2024 to May 2024, Ms. Kast served as the interim President and CEO of the Company and was appointed as the Vice President, General Counsel and CAO of the Company on July 1, 2024. During 2024, Ms. Kast earned a $20,000 bonus for her work as interim President and CEO of the Company and a $80,000 discretionary bonus which was paid in January 2025. During 2025, Ms. Kast earned an $85,000 discretionary bonus which was paid in January 2026. During 2024, all other compensation includes a $7,750 employer 401K matching contribution and $27,750 in director’s fees. During 2025, all other compensation includes a $6,000 healthcare allowance,a $1,200 cell phone allowance and a $21,000 employer 401K matching contribution. |
| (3) | Mr. Rich was appointed as the Chief Financial Officer of the Company on March 28, 2022. During 2024, all other compensation includes a $18,575 employer 401K matching contribution. During 2025, all other compensation includes a $6,000 healthcare allowance, a $1,200 cell phone allowance and a $21,000 employer 401K matching contribution. |
Narrative Discussion of Compensation and Plan-Based Awards
Employment Agreements
The Company has historically maintained employment agreements with its executive officers. The material terms of prior employment agreements have included (a) employment for an indefinite term unless employment is terminated as provided in the agreement; (b) severance arrangements, including upon a change in control; (c) a base salary; and (d) participation in the stock option plans of the Company (as described below), the incentive bonus, and the Company’s benefit plans as are from time to time available to executive officers of the Company.
Kenneth J. Mushinski
Mr. Mushinski entered into an employment agreement with the Company effective May 1, 2024 (the “Mushinski Employment Agreement”). Pursuant to the terms of the Mushinski Employment Agreement, (i) Mr. Mushinski’s initial annual base salary was $320,000 and is subject to adjustment at the Company’s discretion; (ii) Mr. Mushinski will be eligible to receive an annual performance bonus and such long-term incentive awards as may be determined by the Board; and (iii) Mr. Mushinski will be eligible to participate in the employee benefit programs, if offered, by the Company.
Additionally, Mr. Mushinski is entitled to separation benefits in the event that his employment is terminated by the Company without “cause” or by Mr. Mushinski for “good reason” (in each case, as defined in the Mushinski Employment Agreement) due to certain reasons, including a material change in title or duties, a material reduction in compensation, a material breach of the Mushinski Employment Agreement by the Company, or a failure by the Company to maintain reasonable D&O insurance, in each case which the Company has failed to cure. The severance payment to be received by Mr. Mushinski upon termination under the circumstances described above, provided that Mr. Mushinski executes a general release in favor of the Company and has been with the Company for a minimum of two years from the effective date of the Mushinski Employment Agreement, will be equal to one year of Mr. Mushinski’s base salary in effect on the date of termination and paid to Mr. Mushinski in a lump sum 60 days after the date of such termination. In addition, Mr. Mushinski equity incentive awards will vest automatically upon such termination.
Kelli C. Kast
Ms. Kast entered into an employment agreement with the Company effective July 1, 2024 (the “Kast Employment Agreement”). Pursuant to the terms of the Kast Employment Agreement, (i) Ms. Kast’s initial annual base salary was $310,000 and is subject to adjustment at the Company’s discretion; (ii) Ms. Kast will be eligible to receive an annual performance bonus and such long-term incentive awards as may be determined by the Board; and (iii) Ms. Kast will be eligible to participate in the employee benefit programs, if offered, by the Company.
Additionally, Ms. Kast is entitled to separation benefits in the event that her employment is terminated by the Company without “cause” or by Ms. Kast for “good reason” (in each case, as defined in the Kast Employment Agreement) due to certain reasons, including a material change in title or duties, a material reduction in compensation, a material breach of the Kast Employment Agreement by the Company, or a failure by the Company to maintain reasonable D&O insurance, in each case which the Company has failed to cure. The severance payment to be received by Ms. Kast upon termination under the circumstances described above will be equal to one year of Ms. Kast’s base salary in effect on the date of termination and paid to Ms. Kast in a lump sum 60 days after the date of such termination. In addition, Ms. Kast’s equity incentive awards will vest automatically upon such termination.
Wayne E. Rich
Mr. Rich has had an employment agreement with the Company since March 28, 2022 (the “Rich Employment Agreement”). Pursuant to the terms of the Rich Employment Agreement, (i) Mr. Rich’s initial annual base salary was $215,000 and is subject to adjustment at the Company’s discretion; (ii) Mr. Rich will be eligible to receive an annual performance bonus and such long-term incentive awards as may be determined by the Board; and (iii) Mr. Rich will be eligible to participate in the employee benefit programs, if offered, by the Company.
Additionally, Mr. Rich is entitled to separation benefits in the event that his employment is terminated by the Company without “cause” or by Mr. Rich for “good reason” (in each case, as defined in the Rich Employment Agreement) due to certain reasons, including a material change in title or duties, a material reduction in compensation, a material geographic relocation, a material breach of the Rich Employment Agreement by the Company, or a failure by the Company to maintain reasonable D&O insurance, in each case which the Company has failed to cure. The severance payment to be received by Mr. Rich upon termination under the circumstances described above will be equal to one year of Mr. Rich’s base salary in effect on the date of termination and paid to Mr. Rich in a lump sum 60 days after the date of such termination. In addition, Mr. Rich’s equity incentive awards will vest automatically upon such termination.
Equity Plan
As of March 12, 2026, there were 2,685,000 and 820,000 stock options outstanding, respectively, under the 2011 and 2022 Plans, representing approximately 0.5% of the current outstanding common shares. The 2011 Plan was terminated effective as of August 23, 2022. Then-existing awards granted under the 2011 Plan will remain outstanding in accordance with their terms, but new equity awards are being granted solely under the 2022 Plan.
Outstanding Equity Awards at Fiscal Year-End
The following table sets forth the outstanding option awards held by the NEOs of the Company as of December 31, 2025.
Outstanding Equity Awards at Fiscal Year-End
| | | | | | | | | |
|---|---|---|---|---|---|---|---|---|
| · · Option Awards | ||||||||
| Name | | Number of Securities Underlying Unexercised Options (#) Exercisable | | Number of Securities Underlying Unexercised Options (#) Unexercisable | | Option Exercise Price ($) | | Option Expiration Date |
| Kenneth J. Mushinski | | — | | — | | — | | — |
| Kelli C. Kast | | 225,000 | | — | | $ 2.25 | | 4/13/2031 |
| | | 500,000 | | — | | $ 1.42 | | 1/5/2032 |
| | | 225,000 | | — | | $ 0.38 | | 1/4/2033 |
| Wayne E. Rich | | 125,000 | | — | | $ 0.38 | | 1/4/2033 |
| | | 125,000 | | — | | $ 1.20 | | 3/28/2032 |
Potential Payments upon Termination
Pursuant to the employment agreements with Mr. Mushinski, Ms. Kast, and Mr. Rich, each NEO is entitled to separation benefits in the event that his or her employment is or was terminated by the Company without “cause” or by such NEO for “good reason” (in each case, as defined in the applicable employment agreement) due to certain reasons, including a material change in title or duties, a material reduction in compensation, a material geographic relocation, or a material breach of such employment agreement by the Company, in each case which the Company has failed to cure. The separation benefits to be received by such NEO upon termination under the circumstances described above must equal such NEO’s base salary in effect on the date of termination. The separation benefits are not contingent upon any change in control and are to be paid to such NEO in a lump sum 60 days after the date of such termination. In addition, such NEO’s equity incentive awards vest automatically upon such termination.
The table below sets out the estimated payments due to the applicable NEO employed by the Company as of December 31, 2025 on a qualifying termination without cause, assuming termination took place pursuant to such employment agreement.
| | | |
|---|---|---|
| Name | Base Salary | Total |
| Kenneth J. Mushinski | $350,000 | $350,000 |
| Kelli C. Kast | $322,400 | $322,400 |
| Wayne E. Rich | $275,000 | $275,000 |
Director Compensation
Non-employee directors, other than the Board Chair, Audit Committee Chair, Chair of the Nominating, Corporate Governance and Compensation Committee and the Synchron director designees, were entitled to annual compensation of $58,000 during the fiscal year ended December 31, 2025 while the Board Chair, Audit Committee Chair, and Chair of the
Nominating, Corporate Governance and Compensation Committee were entitled to total annual compensation of $85,250, $72,000 and $72,000, respectively. In addition, each director was entitled to an additional committee member fee of $2,000 for each committee on which the director served but of which the director was not the committee chair of. Each director’s compensation was paid in cash quarterly and on a pro-rata basis. The Synchron director designees elected not to receive any director compensation.
The following table sets forth information regarding the compensation received by each of the Company’s non-employee directors during the fiscal year ended December 31, 2025:
Director Compensation
| | | | | |
|---|---|---|---|---|
| | | Fees earned | | Total |
| Name | | ($) | | ($) |
| Gerald W. Grandey | | 87,250 | | 87,250 |
| Bart S. Brundage (1) | | — | | — |
| Nicole J. Champine (1) | | — | | — |
| Craig S. Bartels (1) | | — | | — |
| Pamela L. Saxton | | 62,000 | | 62,000 |
| Paul J. Hickey | | 60,000 | | 60,000 |
| (1) | Synchron’s director designees on the Board, Ms. Champine and Messrs. Brundage and Bartels elected not to receive any director compensation, including stock options. |
Policies and Practices for Granting Stock Options and Stock Appreciation Rights
While we do not have a formal written policy in place with regard to the timing of stock option and stock appreciation rights awards in relation to the disclosure of material nonpublic information, the NCG&C Committee does not seek to time equity grants to take advantage of information, either positive or negative, about the Company that has not been publicly disclosed. Previous awards of stock options have generally been made in tandem with and at the same time that the Company has issued other types of equity awards as part of its ordinary annual grant practices. Stock option grants, if made, are effective on the date the award determination is made by the NCG&C Committee, and the exercise price of stock options is the closing market price of the Common Shares on the last trading day immediately preceding the date of grant.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.